Navigation Links
Hepatitis C Therapeutics Market - Taiwan
Date:8/2/2010

NEW YORK, Aug. 2 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Hepatitis C Therapeutics Market - Taiwan

http://www.reportlinker.com/p0236386/Hepatitis-C-Therapeutics-Market---Taiwan.html

This research service aims to provide an update on the epidemiology of Hepatitis C, including the prevalence and incidence, Market Engineering measurements, and government initiatives. It also covers patient source, load, and forecasts, while also outlining the key treaters involved. Current diagnostic methods are presented, followed by treatment regimens, their cost, and upcoming product launches. Clinical trials highlighting research into new treatments are also provided, along with an analysis of the pipeline. Additionally, there is a competitive analysis which includes the market structure, major participants, and future trends. This service covers the Hepatitis C therapeutics market in Taiwan. 

1 EXECUTIVE SUMMARY

Overview

1. Executive Summary - Taiwan

2 HEPATITIS C THERAPEUTICS MARKET

Market Overview

1. Introduction

2. Context for the Study

3. Report Scope and Segmentation

4. Methodology

5. Restraints in Forecasts

3 TAIWAN HEPATITIS C THERAPEUTICS MARKET

Market Overview

1. Introduction

2. Measurements

3. Government Initiatives

Hepatitis C Patients

1. Patient Load

2. Key Treaters and Patient Flow

3. Patient Forecasts

Diagnosis and Treatment

1. Diagnostic Tests and Monitoring

2. Treatment Regimens

3. Cost of Treatment

4. Product Launches

5. Clinical Trials

Competitive Analysis

1. Competitive Structure

2. Future Trends

3. Challenges Faced by Physicians

4 APPENDIX

Taiwan

1. Appendix-1

List of Figures

Chapter 3

Hepatitis C Therapeutics Market: Prevalence of Hepatitis C (Taiwan), 2006-2016 Hepatitis C Therapeutics Market: Incidence of Hepatitis C (Taiwan), 2006-2016

Hepatitis C Therapeutics Market: Classification of Patients who have Previously Received Interferon-based Therapy (Taiwan), 2009

Hepatitis C Therapeutics Market: Patient Classification of Current HCV Patients Based on Genotype (Taiwan), 2009

Hepatitis C Therapeutics Market: Number of Diagnosed Hepatitis C Patients (Taiwan), 2006-2016

Hepatitis C Therapeutics Market: Market Drivers Ranked in Order of Impact for Treated Chronic Hepatitis C Patient (Taiwan), 2010-2016

Hepatitis C Therapeutics Market: Market Restraints Ranked in Order of Impact for Treated Chronic Hepatitis C Patient (Taiwan), 2010-2016

Hepatitis C Therapeutics Market: Treated and Under Observation Chronic Hepatitis C Patients Forecasts (Taiwan), 2006-2016

Hepatitis C Therapeutics Market: Treated Chronic Hepatitis C Patients Forecasts (Taiwan), 2006-2016

Hepatitis C Therapeutics Market: Circumstances that Prompt Physicians to Test Patients for HCV (Taiwan), 2009

Hepatitis C Therapeutics Market: Key Diagnostic Tests Prior to Hepatitis C Treatment Therapy (Taiwan), 2009

Hepatitis C Therapeutics Market: Diagnostic Tests and Key Clinical Indicators (Taiwan), 2009

Hepatitis C Therapeutics Market: Treatment Regimen for Genotype 1 Chronic HCV Patients (Taiwan), 2009

Hepatitis C Therapeutics Market: Treatment Regimen for Genotype 2 and 3 Chronic HCV Patients (Taiwan), 2009

Hepatitis C Therapeutics Market: Treatment Regimen for Naive Chronic HCV Patients (Taiwan), 2009

Hepatitis C Therapeutics Market: Advantages and Drawbacks of Prescribed Drugs (Taiwan), 2009

Hepatitis C Therapeutics Market: Cost of Therapy (Listed Price) per Patient for Various Drug Regimens for the Treatment of Hepatitis C (Taiwan), 2009 3-29

Hepatitis C Therapeutics Market Product Launches (Taiwan), 2011 and 2013

Hepatitis C Therapeutics Market: List of Clinical Trials Conducted by Phase, Patient Age, Stage, Drug and Sponsor (Taiwan), 2009

Hepatitis C Therapeutics Market: List of Interferons in Development (World), 2009

Hepatitis C Therapeutics Market: List of Small Molecule Antivirals in Development (World), 2009

Hepatitis C Therapeutics Market: List of Non-Interferons in Development (World), 2009

Hepatitis C Therapeutics Market: Competitive Structure (Taiwan), 2009

To order this report:

Drug and Medication Industry: Hepatitis C Therapeutics Market - Taiwan

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Drug in New Hepatitis C Clinical Trial
3. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
4. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
5. Dynavaxs HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial
6. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
7. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
8. Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
9. R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
10. Potent Hepatitis C Virus Inhibitors Show Efficacy and Potential for Once Daily Dosing in Preclinical Studies
11. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ALBANY, New York , February 5, 2016 /PRNewswire/ ... A new Transparency Market Research report states that the ... bn in 2014 and is predicted to reach US$185.9 ... a CAGR of 6.50% from 2014 to 2020. The ... Market: (Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured, by Geography, and by ...
(Date:2/5/2016)... England , February 5, 2016 ... --> Today, VoicePower Ltd - The Speech Recognition People, announced ... been deployed to improve patient care, reduce turnaround times and to ... Wirral CCG ,- VoicePower client since 2013 Challenge: ... Challenge: --> - Six doctors ,- Wirral CCG ...
(Date:2/4/2016)... 4, 2016  The Senior Care Pharmacy Coalition ... Committee Chairman Jason Chaffetz (R-UT) and ... hearing , "Developments in the Prescription Drug ... growing questions about abusive pharmacy benefit manager (PBM) ... and Ranking Member Elijah Cummings (D-MD) are diligent, ...
Breaking Medicine Technology:
(Date:2/6/2016)... ... February 06, 2016 , ... Research ... treatment helps to reduce the frequency and level of relapse. , ... Healthy Identity and Purpose,” will explore the critical tasks of the recovery phase ...
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment and retention ... and scientific initiatives have all marked the last 12 months at Roswell Park ... of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined the many ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... H. Van Allen have signed a joint enrollment and degree completion agreement. ... toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students ...
(Date:2/5/2016)... Pass, OR (PRWEB) , ... February 05, 2016 , ... ... with modern technology, such water may be safer than regular municipal or well water. ... advocate and radio host Sharon Kleyne, could go a long way toward increasing public ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... announced the election of Patrick McDermott as Chairman of the National Board of Directors. ... Pat as Chairman of the Board,” stated Leslie A. Chambers , APDA President ...
Breaking Medicine News(10 mins):